Next generation process for Gamunex-C IgG (Grifols)

N/A

Report date: 2025/12/18 10:33:48

Base Information

Drug NameNext generation process for Gamunex-C IgG (Grifols)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulantsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesGrifols Sa
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A